cetylpyridinium chloride anhydrous and technetium tc 99m exametazime

cetylpyridinium chloride anhydrous has been researched along with technetium tc 99m exametazime in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Nijs, R; Frokjaer, V; Hogh-Rasmussen, E; Knudsen, GM; Svarer, C; Thomsen, G	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and technetium tc 99m exametazime

Article	Year
Required time delay from 99mTc-HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Circulation; Female; Health; Humans; Injections; Male; Middle Aged; Principal Component Analysis; Radioactivity; Subtraction Technique; Technetium Tc 99m Exametazime; Time Factors; Tomography, Emission-Computed, Single-Photon	2008

Article

Year

Required time delay from 99mTc-HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern.

European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Circulation; Female; Health; Humans; Injections; Male; Middle Aged; Principal Component Analysis; Radioactivity; Subtraction Technique; Technetium Tc 99m Exametazime; Time Factors; Tomography, Emission-Computed, Single-Photon

2008